Our Mission

Clarity for when it matters most

At QuantumCyte, we believe the right answer at the right time changes everything—for patients, clinicians, and researchers. That’s why we’ve built the missing link between digital pathology, spatial biology, and molecular testing.

Every biopsy should be a source of insight, not ambiguity. With QCPRECISE, image-based annotation translates directly into molecular clarity—empowering faster, more confident decisions across research, diagnostics, and therapeutic development.

Our team brings together deep expertise in genomics, diagnostics, software engineering, and product development. We’ve worked at the leading edge of health tech, diagnostics, and advanced manufacturing—and we’re applying that experience to one of medicine’s most urgent challenges: delivering clarity at the molecular level, from the very first test.

Our leadership

Carla Leibowitz
Chief Business Officer
Katie Konigsfeld
Scientific Product Manager
Surekha Karudapuram, PhD
Head of Product and Marketing

Advisors

Ron Davis, PhD
Dr. Davis is Professor of Biochemistry and Genetics at Stanford University and Director of the Stanford Genome Technology Center. A pioneer in DNA sequencing and genomics, he has authored over 380 publications, holds more than 60 patents, and his innovations have shaped many of the foundational methods used in modern genetic research.
Dr. Rish Pai
Dr. Pai is the Professor of Pathology and Laboratory Medicine at Mayo Clinic and a leading expert in molecular pathology and precision diagnostics.
Otto Pohl
Otto is the founder of Core Communications and an expert in clarifying strategy in order to build compelling narratives for early-stage, high-growth companies.
Donnie Rizzo
Donnie is the former Senior Director of Oncology & Pathology at Quest Diagnostics and a seasoned healthcare leader and investor.
Jake Doft
Jake is the Founder and CEO of Highline Capital and veteran investor with decades of experience in healthcare and technology.
Jean Davidson, PhD
Jean is a seasoned biotech executive and former senior leader at Genentech and BioMarin with deep expertise in drug development, operations, and commercialization.
Anders Grunnet-Jepsen, PhD
Dr. Grunnet-Jepsen is a physicist and imagining scientist with deep expertise in 3D sensing and semiconductor technologies.
Achin Bhowmik, PhD
Dr. Bhowmik is Adjunct Professor at Stanford School of Medicine and a technology and neuroscience leader focused on the intersection of computational precision and clinical utility.
Board of Directors
John Butler
CEO/CSO and Chairman
Bidhan Chaudhuri, PhD
CTO
Jason Balogh, JD
Secretary

Clear Answers. Better Outcomes.